Trial Profile

Pilot Study of Autologous T Lymphocytes With Antibody-Dependent Cell Cytotoxicity in Patients With CD20-Positive B-Cell Malignancies

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 14 Feb 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs ATTCK 20 (Primary)
Indications Chronic lymphocytic leukaemia; Non-Hodgkin's lymphoma
Focus Adverse reactions; First in man; Therapeutic Use

Most Recent Events

06 Dec 2016 Initial results (n=6) presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
11 Dec 2014 New trial record
01 Dec 2014 Unum Therapeutics announce that recruitment has begun in a media release.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com